Migraine is roughly three times more common in women than in men after puberty, a ratio that emerges with menarche and narrows again after menopause. That timing is not coincidence. Fluctuations in estrogen, particularly falls in estrogen levels, are one of the more reliable triggers of migraine in susceptible people, and understanding the pattern often changes how the condition is managed.
For women who have spent years being told their headaches are stress or hormones, the frustration is understandable. Both statements can be true and still leave you without a plan. The current evidence supports something more specific.
The estrogen-withdrawal pattern
Across the menstrual cycle, estrogen rises through the follicular phase, peaks around ovulation, and drops in the days before menstruation. That premenstrual drop is when many women with migraine experience their most predictable attacks, a pattern often called menstrual migraine.
Two related patterns:
- Pure menstrual migraine, in which attacks occur only in a defined window around bleeding, is less common.
- Menstrually related migraine, in which perimenstrual attacks are more severe and reliable but attacks can occur at other times too, is more common.
Attacks in this pattern tend to be longer, more severe, and less responsive to acute medication than migraines at other times in the cycle. That is not in your head. It is documented in headache clinic data.
Aura, contraception, and stroke
One of the more important distinctions in migraine care is whether a person has migraine with aura, meaning transient neurologic symptoms, most commonly visual, that precede or accompany the headache. This matters beyond diagnosis.
The American College of Obstetricians and Gynecologists and the World Health Organization both flag combined hormonal contraception, meaning pills, patches, and rings that contain estrogen, as generally inappropriate for women with migraine with aura, because of an elevated risk of ischemic stroke. Progestin-only options, IUDs, and non-hormonal methods are generally preferred.
If you have migraines with aura and you are on a combined pill, that is a conversation worth having with your clinician sooner rather than later.
Migraine without aura is compatible with more contraceptive options, though blood pressure, smoking status, and age still factor into the choice.
Perimenopause, menopause, and what to expect
Migraine patterns often shift, and sometimes worsen, during perimenopause, when estrogen levels swing more erratically. For many women, migraine improves after menopause is established and estrogen settles at a low, stable level. For a minority, especially those on cyclic hormone therapy that reproduces monthly withdrawal, migraine can persist or return.
The North American Menopause Society notes that continuous, low-dose transdermal estrogen may be preferable to cyclic or oral regimens for women with a migraine history, as it avoids sharp withdrawal peaks. This is nuanced territory best worked out with a clinician familiar with both headache and menopause.
What actually helps
Modern migraine care has changed substantially in the past decade, and the tools now available go well beyond over-the-counter analgesics.
- Acute treatment. Triptans remain first-line for many attacks, and newer classes such as gepants and ditans expand options for people who cannot take triptans or do not respond.
- Preventive treatment. For frequent attacks, options range from beta-blockers, tricyclics, and topiramate to CGRP monoclonal antibodies and oral CGRP antagonists, which have a strong evidence base and generally favorable tolerability.
- Mini-prophylaxis around menses. For predictable menstrual attacks, short courses of NSAIDs or long-acting triptans starting a day or two before expected onset can be effective.
- Lifestyle inputs. Consistent sleep, hydration, meals, and caffeine intake, and identifying individual triggers, remain part of the foundation.
Overusing acute medications, more than a couple of times a week on a sustained basis, can drive medication-overuse headache and worsen the underlying problem. Preventive therapy exists precisely to break that cycle.
The bottom line
Migraine in women is closely tied to the estrogen cycle, and its patterns across menstruation, contraception, pregnancy, and menopause are well described enough to guide treatment. If your headaches follow your cycle, if you have aura and are on combined contraception, or if perimenopause has scrambled a pattern that used to be predictable, you are describing a treatable neurologic condition, not an unavoidable feature of being a woman. Ask for a plan that reflects both.